新希望-话题@MedSci

#新希望#

160篇内容 | 3464人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1970011, encodeId=56a519e00113e, content=<a href='/topic/show?id=ec345834075' target=_blank style='color:#2F92EE;'>#新希望#</a>, objectTitle=Q Rev Bio Dis: 新希望！MIT开发新蛋白质，或可阻止COVID-19卷起的“致命”风暴, objectType=article, longId=192711, objectId=1064192e1193, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1064192e1193, replyNumber=0, likeNumber=92, createdTime=2020-09-10, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1064192e1193, moduleTitle=Q Rev Bio Dis: 新希望！MIT开发新蛋白质，或可阻止COVID-19卷起的“致命”风暴, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1064192e1193)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969998, encodeId=31ec196999843, content=<a href='/topic/show?id=ec345834075' target=_blank style='color:#2F92EE;'>#新希望#</a>, objectTitle=PACIFIC研究为Ⅲ期不可切除NSCLC患者带来治疗新希望, objectType=article, longId=176070, objectId=aed21e6070a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aed21e6070a0, replyNumber=0, likeNumber=74, createdTime=2020-03-23, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aed21e6070a0, moduleTitle=PACIFIC研究为Ⅲ期不可切除NSCLC患者带来治疗新希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aed21e6070a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969987, encodeId=1968196998e20, content=<a href='/topic/show?id=ec345834075' target=_blank style='color:#2F92EE;'>#新希望#</a>, objectTitle=新希望心同行 -- 乳房再造“援”梦公益救助行动再启程, objectType=article, longId=165819, objectId=ceae165819e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ceae165819e2, replyNumber=0, likeNumber=70, createdTime=2019-09-12, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ceae165819e2, moduleTitle=新希望心同行 -- 乳房再造“援”梦公益救助行动再启程, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ceae165819e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969992, encodeId=854b19699928c, content=<a href='/topic/show?id=ec345834075' target=_blank style='color:#2F92EE;'>#新希望#</a>, objectTitle=HR+晚期乳腺癌内分泌治疗优先再添力证！Young-PEARL为绝经前HR+晚期乳腺癌患者带来新希望, objectType=article, longId=167917, objectId=760c16e91728, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=760c16e91728, replyNumber=0, likeNumber=59, createdTime=2019-07-22, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=760c16e91728, moduleTitle=HR+晚期乳腺癌内分泌治疗优先再添力证！Young-PEARL为绝经前HR+晚期乳腺癌患者带来新希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=760c16e91728)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1970002, encodeId=ac3819e0002f0, content=<a href='/topic/show?id=ec345834075' target=_blank style='color:#2F92EE;'>#新希望#</a>, objectTitle=Cell Death Dis：治愈新希望！直捣肝癌转移与耐药关键点, objectType=article, longId=180171, objectId=d44c1801e1ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d44c1801e1ce, replyNumber=0, likeNumber=83, createdTime=2019-12-28, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d44c1801e1ce, moduleTitle=Cell Death Dis：治愈新希望！直捣肝癌转移与耐药关键点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d44c1801e1ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1970000, encodeId=0d9b19e0000ec, content=<a href='/topic/show?id=ec345834075' target=_blank style='color:#2F92EE;'>#新希望#</a>, objectTitle=Sco;Robot：新希望！微型机器人或将奋战抗肿瘤前线, objectType=article, longId=176262, objectId=6fb61e62623e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6fb61e62623e, replyNumber=0, likeNumber=65, createdTime=2020-06-20, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6fb61e62623e, moduleTitle=Sco;Robot：新希望！微型机器人或将奋战抗肿瘤前线, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6fb61e62623e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969989, encodeId=d6ed19699893b, content=<a href='/topic/show?id=ec345834075' target=_blank style='color:#2F92EE;'>#新希望#</a>, objectTitle=FAKTION研究: PI3K/AKT通路抑制剂带来新希望, objectType=article, longId=167060, objectId=e32e16e06047, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e32e16e06047, replyNumber=0, likeNumber=87, createdTime=2020-04-26, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e32e16e06047, moduleTitle=FAKTION研究: PI3K/AKT通路抑制剂带来新希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e32e16e06047)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969999, encodeId=f17f1969999e0, content=<a href='/topic/show?id=ec345834075' target=_blank style='color:#2F92EE;'>#新希望#</a>, objectTitle=Sci Robotics：新希望！微型机器人或将奋战抗肿瘤前线, objectType=article, longId=176192, objectId=56fa1e619278, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56fa1e619278, replyNumber=0, likeNumber=54, createdTime=2020-05-01, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56fa1e619278, moduleTitle=Sci Robotics：新希望！微型机器人或将奋战抗肿瘤前线, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56fa1e619278)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969995, encodeId=389e196999560, content=<a href='/topic/show?id=ec345834075' target=_blank style='color:#2F92EE;'>#新希望#</a>, objectTitle=J Clin Oncol:局部晚期肺癌新希望——JCO发表CTONG 1103靶向-手术-靶向多中心研究成果, objectType=article, longId=168698, objectId=ca0c168698eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca0c168698eb, replyNumber=0, likeNumber=75, createdTime=2019-11-22, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca0c168698eb, moduleTitle=J Clin Oncol:局部晚期肺癌新希望——JCO发表CTONG 1103靶向-手术-靶向多中心研究成果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca0c168698eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969993, encodeId=5f5219699936d, content=<a href='/topic/show?id=ec345834075' target=_blank style='color:#2F92EE;'>#新希望#</a>, objectTitle=阿帕替尼+卡瑞利珠单抗联合出击，为NSCLC患者带来新希望, objectType=article, longId=168141, objectId=9b1716814124, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b1716814124, replyNumber=0, likeNumber=83, createdTime=2019-06-27, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b1716814124, moduleTitle=阿帕替尼+卡瑞利珠单抗联合出击，为NSCLC患者带来新希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b1716814124)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969986, encodeId=f98a1969986d0, content=<a href='/topic/show?id=ec345834075' target=_blank style='color:#2F92EE;'>#新希望#</a>, objectTitle=张奕：高压氧为儿童自闭症的治疗带来新希望, objectType=article, longId=159157, objectId=c32e15915e27, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c32e15915e27, replyNumber=0, likeNumber=82, createdTime=2019-07-01, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c32e15915e27, moduleTitle=张奕：高压氧为儿童自闭症的治疗带来新希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c32e15915e27)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1970003, encodeId=77e819e0003cb, content=<a href='/topic/show?id=ec345834075' target=_blank style='color:#2F92EE;'>#新希望#</a>, objectTitle=高明教授：RET高选择性抑制剂Selpercatinib(LOXO-292)给甲状腺癌患者带来新希望, objectType=article, longId=181524, objectId=3d71181524a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d71181524a9, replyNumber=0, likeNumber=63, createdTime=2020-09-18, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d71181524a9, moduleTitle=高明教授：RET高选择性抑制剂Selpercatinib(LOXO-292)给甲状腺癌患者带来新希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d71181524a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1970001, encodeId=fdbe19e0001ce, content=<a href='/topic/show?id=ec345834075' target=_blank style='color:#2F92EE;'>#新希望#</a>, objectTitle=手术治疗为难治性癫痫患者带来新希望, objectType=article, longId=178986, objectId=329a1e898696, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=329a1e898696, replyNumber=0, likeNumber=85, createdTime=2020-04-27, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=329a1e898696, moduleTitle=手术治疗为难治性癫痫患者带来新希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=329a1e898696)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969990, encodeId=03771969990f6, content=<a href='/topic/show?id=ec345834075' target=_blank style='color:#2F92EE;'>#新希望#</a>, objectTitle=替雷利珠单抗为多种中国高发肿瘤带来新希望, objectType=article, longId=167062, objectId=cfcd16e06299, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cfcd16e06299, replyNumber=0, likeNumber=73, createdTime=2019-10-21, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cfcd16e06299, moduleTitle=替雷利珠单抗为多种中国高发肿瘤带来新希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cfcd16e06299)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969984, encodeId=941f196998423, content=<a href='/topic/show?id=ec345834075' target=_blank style='color:#2F92EE;'>#新希望#</a>, objectTitle=NEJM：三阴性乳腺癌免疫治疗的新希望, objectType=article, longId=151758, objectId=3009151e58ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3009151e58ed, replyNumber=0, likeNumber=50, createdTime=2019-08-16, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3009151e58ed, moduleTitle=NEJM：三阴性乳腺癌免疫治疗的新希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3009151e58ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969988, encodeId=5423196998833, content=<a href='/topic/show?id=ec345834075' target=_blank style='color:#2F92EE;'>#新希望#</a>, objectTitle=罕见肿瘤需要MDT，免疫治疗带来生存新希望, objectType=article, longId=166864, objectId=246b1668640e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=246b1668640e, replyNumber=0, likeNumber=0, createdTime=2020-03-20, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=246b1668640e, moduleTitle=罕见肿瘤需要MDT，免疫治疗带来生存新希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=246b1668640e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969996, encodeId=64af196999699, content=<a href='/topic/show?id=ec345834075' target=_blank style='color:#2F92EE;'>#新希望#</a>, objectTitle=杨帆教授：靶向治疗和免疫治疗为Ⅲ期NSCLC带来新希望, objectType=article, longId=175201, objectId=e5a31e52010e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5a31e52010e, replyNumber=0, likeNumber=68, createdTime=2019-12-30, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5a31e52010e, moduleTitle=杨帆教授：靶向治疗和免疫治疗为Ⅲ期NSCLC带来新希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5a31e52010e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969991, encodeId=8bec1969991e0, content=<a href='/topic/show?id=ec345834075' target=_blank style='color:#2F92EE;'>#新希望#</a>, objectTitle=CDK4/6抑制剂联合方案给HR+/HER2-乳腺癌患者带来的新希望, objectType=article, longId=167338, objectId=864316e338a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=864316e338a0, replyNumber=0, likeNumber=49, createdTime=2019-10-05, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=864316e338a0, moduleTitle=CDK4/6抑制剂联合方案给HR+/HER2-乳腺癌患者带来的新希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=864316e338a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969994, encodeId=bfe2196999453, content=<a href='/topic/show?id=ec345834075' target=_blank style='color:#2F92EE;'>#新希望#</a>, objectTitle=哌柏西利联合方案为绝经前HR+晚期乳腺癌患者带来新希望！, objectType=article, longId=168153, objectId=1b2d1681532a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b2d1681532a, replyNumber=0, likeNumber=74, createdTime=2020-03-12, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b2d1681532a, moduleTitle=哌柏西利联合方案为绝经前HR+晚期乳腺癌患者带来新希望！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b2d1681532a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969985, encodeId=a9021969985ef, content=<a href='/topic/show?id=ec345834075' target=_blank style='color:#2F92EE;'>#新希望#</a>, objectTitle=优时比创新疗法在中国上市，为帕金森病患者带来新希望, objectType=article, longId=152789, objectId=fe2a152e89ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe2a152e89ff, replyNumber=0, likeNumber=70, createdTime=2018-12-13, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe2a152e89ff, moduleTitle=优时比创新疗法在中国上市，为帕金森病患者带来新希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe2a152e89ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

新希望

2020-05-29

珙桐 (审核中...)

前往app查看评论内容

#新希望#

Q Rev Bio Dis: 新希望！MIT开发新蛋白质，或可阻止COVID-19卷起的“致命”风暴

2020-09-10

珙桐 (审核中...)

前往app查看评论内容

#新希望#

PACIFIC研究为Ⅲ期不可切除NSCLC患者带来治疗新希望

2020-03-23

珙桐 (审核中...)

前往app查看评论内容

#新希望#

新希望心同行 -- 乳房再造“援”梦公益救助行动再启程

2019-09-12

珙桐 (审核中...)

前往app查看评论内容

#新希望#

HR+晚期乳腺癌内分泌治疗优先再添力证！Young-PEARL为绝经前HR+晚期乳腺癌患者带来新希望

2019-07-22

珙桐 (审核中...)

前往app查看评论内容

#新希望#

Cell Death Dis：治愈新希望！直捣肝癌转移与耐药关键点

2019-12-28

珙桐 (审核中...)

前往app查看评论内容

#新希望#

Sco;Robot：新希望！微型机器人或将奋战抗肿瘤前线

2020-06-20

珙桐 (审核中...)

前往app查看评论内容

#新希望#

FAKTION研究: PI3K/AKT通路抑制剂带来新希望

2020-04-26

珙桐 (审核中...)

前往app查看评论内容

#新希望#

Sci Robotics：新希望！微型机器人或将奋战抗肿瘤前线

2020-05-01

珙桐 (审核中...)

前往app查看评论内容

#新希望#

J Clin Oncol:局部晚期肺癌新希望——JCO发表CTONG 1103靶向-手术-靶向多中心研究成果

2019-11-22

珙桐 (审核中...)

前往app查看评论内容

#新希望#

阿帕替尼+卡瑞利珠单抗联合出击，为NSCLC患者带来新希望

2019-06-27

珙桐 (审核中...)

前往app查看评论内容

#新希望#

张奕：高压氧为儿童自闭症的治疗带来新希望

2019-07-01

珙桐 (审核中...)

前往app查看评论内容

#新希望#

高明教授：RET高选择性抑制剂Selpercatinib(LOXO-292)给甲状腺癌患者带来新希望

2020-09-18

珙桐 (审核中...)

前往app查看评论内容

#新希望#

手术治疗为难治性癫痫患者带来新希望

2020-04-27

珙桐 (审核中...)

前往app查看评论内容

#新希望#

替雷利珠单抗为多种中国高发肿瘤带来新希望

2019-10-21

珙桐 (审核中...)

前往app查看评论内容

#新希望#

NEJM：三阴性乳腺癌免疫治疗的新希望

2019-08-16

珙桐 (审核中...)

前往app查看评论内容

#新希望#

罕见肿瘤需要MDT，免疫治疗带来生存新希望

2020-03-20

珙桐 (审核中...)

前往app查看评论内容

#新希望#

杨帆教授：靶向治疗和免疫治疗为Ⅲ期NSCLC带来新希望

2019-12-30

珙桐 (审核中...)

前往app查看评论内容

#新希望#

CDK4/6抑制剂联合方案给HR+/HER2-乳腺癌患者带来的新希望

2019-10-05

珙桐 (审核中...)

前往app查看评论内容

#新希望#

哌柏西利联合方案为绝经前HR+晚期乳腺癌患者带来新希望！

2020-03-12

珙桐 (审核中...)

前往app查看评论内容

#新希望#

优时比创新疗法在中国上市，为帕金森病患者带来新希望

2018-12-13

科室
- - 订阅+
  - 更多科室
工具
服务